28th International Conference on Cancer Research and Pharmacology

PARIS - March 17, 2020 - PRLog -- Cancer Research 2020 will enlighten the public with recent advances in Cancer diagnosis, Cancer therapy and Pharmacology around the world and to sharpen the related ideas about Cancer Research. Moreover, Cancer Research 2020 provides you a great networking with peers. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are the trademark of this conference. Cancer conferences, symposiums, and Workshops provide a dedicated forum for the advancement, execution, and exchange of information about Oncology and Cancer. Cancer Research 2020 is an extraordinary event designed for International medical health professionals, Pharmacologists and oncologists to facilitate the dissemination and application of research findings related to Cancer. The Cancer Research Conference invites participants from all leading universities, clinical research institutions, and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques. Cancer Research 2020 provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking. The main aim of this conference is to provide Informative Sessions on Cancer and Pharmacology Research: Challenges and Achievements.

Theme: Conquering Cancer with the Modern progression

Conference Website:  https://cancer.cmesociety.com/

Important Conference Highlights:

Radiation Oncology

Neuro-Oncology

Cancer Imaging and Early Detection

Cancer Screening and Diagnosis

Biology of Pediatric and Young Adult Cancer

Radiology and Imaging Technologies

Cancer Nanotechnology

Oncology Nursing Care

Cancer Nanomedicine

Cancer Prevention Vaccines

Advances in Pharmacological Research

Therapeutic Innovation in Pharmacology

Pediatrics Pharmacology

Past Conference Speaker Highlights (Cancer Research 2019):

Keynote talk:

Title: Noninvasive risk stratification of patients using predictive biomarker apoptosis index of tumors

Raghu Pandurangi, Sci-Engi-Medco Solutions Inc. and Amplexi-LLC, USA

Title: Hydrogen peroxide inducible clone-5 mediates positive feedback ROS-JNK-c-jun signaling for HCC progression

Wen-Sheng Wu,Tzu Chi University, Taiwan

Title: Role of biochemistry in industrial waste water treatment processes

Mukesh Pandya, Jaihind College, India

Title: In silico modeling of Bcr-Abl oncoprotein isoforms in chronic myelogenous leukemia

Entissar S AlSuhaibani, King Saud University, KSA

Our targeted Audience:

Oncologists, Pharmacologists, Pharma Practitioners, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Undergraduate & Postgraduate students, researchers, business professionals, Postdoctoral fellows and Trainees, Cancer Diagnostics Associations and Societies